Browse bulletin items by A-Z

Published: 14 October, 2021


Contents

We are on the move!

Our bulletin is a day early this week and a bit shorter than usual because we are shifting offices. bpacnz and our associated organisations (New Zealand Formulary, BPAC Clinical Solutions, Inpractice and Southlink Health Services) are packing our books, computers, furniture, coffee mugs and almost 20 years of history and moving to our exciting new premises at 5 Melville Street, Dunedin. Our contact phone numbers and emails will remain the same.


New healthy eating guidelines for babies/toddlers

The Ministry of Health has released new evidence-based guidelines that provide updated recommendations for nutrition for children aged under two years. The guidelines are set out in six sections or “Eating Statements” which cover all the requirements and recommendations for healthy eating from birth to age two years. A two-page summary is also provided that can be downloaded and printed out for parents and caregivers.

Look out for our upcoming article: "Plant-based diets: are they healthy for a child?"


Guidelines for helping people to stop smoking

In September, updated guidance was released by the Ministry of Health to provide health care professionals with the latest evidence for smoking cessation interventions in New Zealand. The new guidelines replace previous smoking cessation guidelines from 2007 and 2014. Guidance remains focused on the ABC pathway but with increased emphasis on providing an offer of cessation support or referring people to a smoking cessation service. It is hoped that the guidelines will provide an increased focus on achieving the Smokefree 2025 goal set in 2011, as currently New Zealand is not on track to meet this. There is also an emphasis on improving health equity as smoking rates remain higher for Māori and Pacific peoples compared to the population as a whole.


Testosterone cypionate (Depo-Testosterone) out of stock

PHARMAC has been informed by Pfizer that testosterone cypionate injections (100 mg/mL, 10 mL vial) will be out of stock from October, 2021 until September, 2022. This is because the manufacturing site that produces this medicine in the United States is being used to make COVID-19 products and the volume of other medicines made at this site has had to be reduced. There are two other funded testosterone injection products available and these are suitable alternatives. Dosing instructions for these alternative products can be found here.


COVID-19 Resources: Managing patients in the community

New Zealand is at a crucial turning point in the ongoing battle against COVID-19. Most of us await the daily media reports with some anxiety and continually speculate with colleagues, family and friends about what might happen next. We are aware that many in primary care are keen to be better prepared and to have plans in place for the management of people with COVID-19 in the community. The experience of primary care clinicians in other countries is likely to be valuable while we await specific guidance for New Zealand.


If you have any information you would like us to add to our next bulletin, please email: editor@bpac.org.nz

ASK A COLLEAGUE: Are they receiving these bulletins? Sign up to our mailing list here

Made with by the bpacnz team

Partner links